SE7701667L - Forfarande for framstellning av cefalosporin-antibiotika - Google Patents

Forfarande for framstellning av cefalosporin-antibiotika

Info

Publication number
SE7701667L
SE7701667L SE7701667A SE7701667A SE7701667L SE 7701667 L SE7701667 L SE 7701667L SE 7701667 A SE7701667 A SE 7701667A SE 7701667 A SE7701667 A SE 7701667A SE 7701667 L SE7701667 L SE 7701667L
Authority
SE
Sweden
Prior art keywords
cefalosporin
antibiotics
procedure
preparation
cefalosporin antibiotics
Prior art date
Application number
SE7701667A
Other languages
English (en)
Other versions
SE432255B (sv
Inventor
M Gregson
R B Sykes
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB6010/76A external-priority patent/GB1572993A/en
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE7701667L publication Critical patent/SE7701667L/sv
Publication of SE432255B publication Critical patent/SE432255B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE7701667A 1976-02-16 1977-02-15 Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2metoxiiminoacetamido)-cef-3-em-4-karbonsyra SE432255B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB6010/76A GB1572993A (en) 1976-02-16 1976-02-16 Ester derivatives of cefuroxime
GB2730076 1976-06-30

Publications (2)

Publication Number Publication Date
SE7701667L true SE7701667L (sv) 1977-08-17
SE432255B SE432255B (sv) 1984-03-26

Family

ID=26240323

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701667A SE432255B (sv) 1976-02-16 1977-02-15 Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2metoxiiminoacetamido)-cef-3-em-4-karbonsyra

Country Status (14)

Country Link
US (1) US4446317A (sv)
JP (1) JPS52100493A (sv)
AT (1) AT358726B (sv)
CA (1) CA1093549A (sv)
CH (1) CH629814A5 (sv)
DE (1) DE2706360A1 (sv)
DK (1) DK63777A (sv)
ES (1) ES455918A1 (sv)
FR (1) FR2340951A1 (sv)
IE (1) IE44698B1 (sv)
IL (1) IL51451A (sv)
NL (1) NL7701567A (sv)
SE (1) SE432255B (sv)
YU (1) YU41077A (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
SE9804002D0 (sv) 1998-11-23 1998-11-23 Astra Ab New manufacturing process

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1453049A (en) * 1973-08-21 1976-10-20 Glaxo Lab Ltd Cephalosporing antibiotics
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids
GB1406113A (en) * 1972-10-05 1975-09-17 Leo Pharm Prod Ltd Process for the preparation of cephalosporin estets
PL98296B1 (pl) * 1973-02-07 1978-04-29 Politechnika Gdanskapo Sposob otrzymywania estrow acetoksymetylowych cefalosporyn
US3962227A (en) * 1973-02-23 1976-06-08 Eli Lilly And Company 3-halo cephalosporins
DE2460537A1 (de) * 1973-12-21 1975-07-03 Glaxo Lab Ltd Cephalosporin-antibiotika
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics

Also Published As

Publication number Publication date
AT358726B (de) 1980-09-25
FR2340951B1 (sv) 1981-11-06
NL7701567A (nl) 1977-08-18
SE432255B (sv) 1984-03-26
US4446317A (en) 1984-05-01
ES455918A1 (es) 1978-01-01
DE2706360A1 (de) 1977-08-18
CH629814A5 (de) 1982-05-14
ATA100577A (de) 1980-02-15
JPS52100493A (en) 1977-08-23
YU41077A (en) 1982-06-30
IL51451A (en) 1980-12-31
DK63777A (da) 1977-08-17
IL51451A0 (en) 1977-04-29
IE44698B1 (en) 1982-02-24
FR2340951A1 (fr) 1977-09-09
CA1093549A (en) 1981-01-13
IE44698L (en) 1977-08-16

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO834236L (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater
SE7702332L (sv) Forfarande for framstellning av cefalosporinforeningar
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE7706518L (sv) Forfarande for framstellning av antibiotika
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE7702139L (sv) Forfarande for framstellning av antibiotika
SE7711961L (sv) Forfarande for framstellning av antibiotika
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE416545B (sv) Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat